73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Modeling the use of beta radiation in cancer treatment

Modeling the use of beta radiation in cancer treatment

bySpringerIllustration of beta decay proceeding against the backdrop of a Monte Carlo simulation. Credit: Robert LeaTreating superficial skin tumors especially when they are located above cartil

Modeling the use of beta radiation in cancer treatment

bySpringerIllustration of beta decay proceeding against the backdrop of a Monte Carlo simulation. Credit: Robert LeaTreating superficial skin tumors especially when they are located above cartil
Quest for better pancreatic cancer tests gains insights from survivor's data

Quest for better pancreatic cancer tests gains insights from survivor's data

byFlinders UniversityCA19-9 and PSA serum levels. (A) CA19-9 and PSA levels from 15th May 2017 to 27th January 2023. (B) Simple linear regression of CA19-9 and PSA at all-time points. Credit:&nb

Quest for better pancreatic cancer tests gains insights from survivor's data

byFlinders UniversityCA19-9 and PSA serum levels. (A) CA19-9 and PSA levels from 15th May 2017 to 27th January 2023. (B) Simple linear regression of CA19-9 and PSA at all-time points. Credit:&nb
Pulsed electromagnetic field application technique for preventing bone loss due to radiotherapy

Pulsed electromagnetic field application technique for preventing bone loss due to radiotherapy

by Bob Yirka , Medical XpressPEMF ameliorates focal radiation–induced bone loss by modulating osteoblasts. (A) Schematic representation of focal radiation and PEMF administration. (B) Representative m

Pulsed electromagnetic field application technique for preventing bone loss due to radiotherapy

by Bob Yirka , Medical XpressPEMF ameliorates focal radiation–induced bone loss by modulating osteoblasts. (A) Schematic representation of focal radiation and PEMF administration. (B) Representative m
A new strategy to attack aggressive brain cancer shrank tumors in two early tests

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w
Is the pap smear on the way out?

Is the pap smear on the way out?

by Steven Reinberg, Healthday Reporter(HealthDay)—The Pap test, used for over 50 years to spot the early signs of cervical cancer, may soon become a thing of the past, new research suggests.Its replac

Is the pap smear on the way out?

by Steven Reinberg, Healthday Reporter(HealthDay)—The Pap test, used for over 50 years to spot the early signs of cervical cancer, may soon become a thing of the past, new research suggests.Its replac
Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for
PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising pr

PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising pr
Wide variation in bowel cancer rates after colonoscopies in England

Wide variation in bowel cancer rates after colonoscopies in England

by British Medical JournalBowel cancer survivor John Barnes. Credit: University of LeedsSubstantial variation exists between colonoscopy providers in rates of bowel cancer up to three years after

Wide variation in bowel cancer rates after colonoscopies in England

by British Medical JournalBowel cancer survivor John Barnes. Credit: University of LeedsSubstantial variation exists between colonoscopy providers in rates of bowel cancer up to three years after
Researchers pinpoint tumor-related protein, slow progression of cancers

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.
Renal impairment linked to worse prognosis in IgD multiple myeloma

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no
Can what works to treat cancer work for diabetes?

Can what works to treat cancer work for diabetes?

by Jess Berthold,University of California, San FranciscoCredit: CC0 Public DomainTo live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only

Can what works to treat cancer work for diabetes?

by Jess Berthold,University of California, San FranciscoCredit: CC0 Public DomainTo live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only
Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta